Treatment with the PPARĪ³ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats
Crossref DOI link: https://doi.org/10.1007/s12975-017-0577-8
Published Online: 2017-11-06
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kinouchi, Tomoya http://orcid.org/0000-0003-3831-4243
Kitazato, Keiko T.
Shimada, Kenji
Yagi, Kenji
Tada, Yoshiteru
Matsushita, Nobuhisa
Kurashiki, Yoshitaka
Satomi, Junichiro
Sata, Masataka
Nagahiro, Shinji
License valid from 2017-11-06